In This Issue
Screening and Identification of Patients With COVID-19
When is conjunctival transmission a concern, and how do asymptomatic carriers affect disease transmission?
Home-Based Glaucoma Monitoring
Tools for expanding glaucoma diagnosis and management beyond the office.
Glaucoma and COVID-19
Despite initial delays in patient care, glaucoma treatment in Wuhan has returned to normal.
Virtual options can almost always be offered to patients with neuro-ophthalmologic conditions.
From Drops to Drug Delivery: Changing the Hearts and Minds of Clinicians
What factors influence a lasting evolution in care?
Sustained Drug Delivery: Real-World Experience
Surgeons describe their initial cases and the insights gained using a new pharmaceutical solution for glaucoma.
Implementing Advances in Drug Delivery
How do new treatment options fit in with existing therapeutic strategies?